Stay updated with breaking news from Etro brands. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Motilal Oswal is bullish on Metro Brands recommended buy rating on the stock with a target price of Rs 1530 in its research report dated January 11, 2024.
Prabhudas Lilladher initiated coverage on Jupiter Life Line Hospitals with 'buy' rating and TP of Rs 1,310. It is a key multispecialty tertiary and quaternary healthcare services in Mumbai.
The partnership aims at transforming the sneaker segment in India, and address the evolving needs of next-gen customers. Under the terms of the agreements, MBL is granted exclusive rights to own and operate Foot Locker stores within India and to sell authorized merchandise in Foot Locker stores whereas Nykaa Fashion will serve as the e-commerce partner and operate Foot Locker's India website and retail authorized merchandise on Foot Locker branded shop on Nykaa’s existing e-commerce platforms.
For Tuesday, a domestic brokerage's share market analyst has assigned 'Buy' calls on Samvardhana Motherson International, Star Cement and Metro Brands. Check share price targets, analysis, investment rationale and other crucial details about these technical bets.
Glenmark Pharma was the biggest gainer not only in the Nifty500 index but also amongst F&O stocks. The stock has formed strong bullish candlestick pattern on the daily scale, with trading above all key moving averages.
Metro Brands: “I am quite confident that we would continue to have EBITDAs north of 30%. We also have the Cravatex acquisition that in the first four quarters of the combination and consolidation of those numbers, it is going to have a negative impact on some of our numbers. But overall, the business is very stable and very sound.”